Acute stress can be detrimental to fighting off infection, especially COVID-19, and increases the chance of dying in mouse models.
May 30, 2022
0
78
It is well established that older adults are more susceptible to infection and their immune systems less capable of generating a strong immune response. Now, a new University of Arizona Health Sciences-led paper explains ...
May 4, 2022
0
94
Expression of a pro-lymphangiogenic growth factor after heart injury activates the lymphatic system, spurring leukocytes to help clear away dying cells, according to a Northwestern Medicine study published in the Journal ...
Apr 6, 2022
0
15
People who were infected with SARS-CoV-2 before being vaccinated generate an immune response more specific to fighting viral infections, and produce a broader antibody response, than do people whose only protection is the ...
Mar 23, 2022
0
81
To quote veteran science writer Ed Yong's simple yet extremely accurate words in The Atlantic, "The immune system is very complicated." As the COVID-19 pandemic had made abundantly clear, science still doesn't fully understand ...
Mar 15, 2022
0
218
Antibodies generated by COVID-19 vaccines are more suited to recognizing viral variants than antibodies that arise from natural infection, according to a study by researchers at Stanford Medicine.
Feb 17, 2022
1
221
In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences. However, only about 20% of patients who received immune ...
Dec 9, 2021
0
138
A common strategy to make vaccines more powerful is to deliver them along with an adjuvant—a compound that stimulates the immune system to produce a stronger response.
Dec 3, 2021
1
137
To an immunologist, autoimmune diseases like Type 1 diabetes are the polar opposite of cancer. In the former, the immune system goes into overdrive and attacks the body's own organs in a relentless manner, eventually causing ...
Nov 30, 2021
0
134
(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.
Nov 17, 2021
0
84
